American Generics (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 23-12-2024
- Paid Up Capital ₹ 2.68 M
as on 23-12-2024
- Company Age 29 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 6.18%
(FY 2019)
- Profit -111.45%
(FY 2019)
- Ebitda -1347.44%
(FY 2019)
- Net Worth -1.73%
(FY 2019)
- Total Assets 4.90%
(FY 2019)
About American Generics (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 2.68 M, as per Ministry of Corporate Affairs (MCA) records.
Sunil Srivastava, Bhupendera Ramakrishnan, Lalitha Ramakrishnan, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239TG1995PLC020046
- Company No.
020046
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
19 Apr 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- LocationHyderabad, Telangana
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at American Generics (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkatasubrahmanyan Ramakrishnan  | Managing Director | 19-Apr-1995 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhupendera Ramakrishnan | Director | 28-May-2018 | Current |
| Sunil Srivastava | Director | 19-Apr-1995 | Current |
| Lalitha Ramakrishnan | Director | 04-Jul-2001 | Current |
Financial Performance of American Generics (India).
American Generics (India) Limited, for the financial year ended 2019, experienced modest growth in revenue, with a 6.18% increase. The company also saw a substantial fall in profitability, with a 111.45% decrease in profit. The company's net worth dipped by a decrease of 1.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of American Generics (India)?
In 2018, American Generics (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Balaji Rail Road Systems Private LimitedActive 36 years 2 monthsSunil Srivastava and Venkatasubrahmanyan Ramakrishnan are mutual person
Lipicard Technologies LimitedActive 18 years 11 monthsSunil Srivastava and Venkatasubrahmanyan Ramakrishnan are mutual person
- Integrated Rail Services Private LimitedActive 13 years 4 months
Sunil Srivastava and Venkatasubrahmanyan Ramakrishnan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at American Generics (India)?
Unlock and access historical data on people associated with American Generics (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of American Generics (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped American Generics (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
